Hims & Hers Health Inc (NYSE:HIMS) shares, rose in value on Thursday, July 10, with the stock price down by -1.89% to the previous day’s close as strong demand from buyers drove the stock to $50.27.
Actively observing the price movement in the last trading, the stock closed the session at $51.24, falling within a range of $50.0 and $51.93. The value of beta (5-year monthly) was 2.097 whereas the PE ratio was 73.17 over 12-month period. Referring to stock’s 52-week performance, its high was $72.98, and the low was $13.47. On the whole, HIMS has fluctuated by -11.59% over the past month.
With the market capitalization of Hims & Hers Health Inc currently standing at about $11.25 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-05.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that HIMS’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 2.12, with the price of HIMS currently trading nearly -2.26% and -3.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.35, while the 7-day volatility ratio is showing 5.92% which for the 30-day chart, stands at 7.93%. Furthermore, Hims & Hers Health Inc (HIMS)’s beta value is 2.07.
A comparison of Hims & Hers Health Inc (HIMS) with its peers suggests the former has fared considerably weaker in the market. HIMS showed an intraday change of -1.89% in last session, and over the past year, it grew by 107.90%%.
Data on historical trading for Hims & Hers Health Inc (NYSE:HIMS) indicates that the trading volumes over the past 10 days have averaged 38.04 and over the past 3 months, they’ve averaged 46.07 million. According to company’s latest data on outstanding shares, there are 215.21 million shares outstanding.
Nearly 14.80% of Hims & Hers Health Inc’s shares belong to company insiders and institutional investors own 70.43% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 61.69 million shares as on 2025-06-13, resulting in a short ratio of 1.47. According to the data, the short interest in Hims & Hers Health Inc (HIMS) stood at 3423.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 62.34 million. The stock has risen by 145.10% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HIMS stock heading into the next quarter.
